JP2008502323A5 - - Google Patents

Download PDF

Info

Publication number
JP2008502323A5
JP2008502323A5 JP2007511077A JP2007511077A JP2008502323A5 JP 2008502323 A5 JP2008502323 A5 JP 2008502323A5 JP 2007511077 A JP2007511077 A JP 2007511077A JP 2007511077 A JP2007511077 A JP 2007511077A JP 2008502323 A5 JP2008502323 A5 JP 2008502323A5
Authority
JP
Japan
Prior art keywords
protein
modified
composition
human
complement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007511077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008502323A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/015119 external-priority patent/WO2005107785A2/en
Publication of JP2008502323A publication Critical patent/JP2008502323A/ja
Publication of JP2008502323A5 publication Critical patent/JP2008502323A5/ja
Pending legal-status Critical Current

Links

JP2007511077A 2004-04-30 2005-04-29 コブラ毒因子様機能を有するヒト補体ｃ３誘導体 Pending JP2008502323A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US56706904P 2004-04-30 2004-04-30
US65324705P 2005-02-14 2005-02-14
US66735205P 2005-03-31 2005-03-31
PCT/US2005/015119 WO2005107785A2 (en) 2004-04-30 2005-04-29 Human complement c3 derivates with cobra venom factor-like function

Publications (2)

Publication Number Publication Date
JP2008502323A JP2008502323A (ja) 2008-01-31
JP2008502323A5 true JP2008502323A5 (enExample) 2008-05-29

Family

ID=35320733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007511077A Pending JP2008502323A (ja) 2004-04-30 2005-04-29 コブラ毒因子様機能を有するヒト補体ｃ３誘導体

Country Status (9)

Country Link
US (2) US8632780B2 (enExample)
EP (1) EP1755658A4 (enExample)
JP (1) JP2008502323A (enExample)
KR (1) KR20070036057A (enExample)
AU (1) AU2005240096A1 (enExample)
CA (1) CA2565227A1 (enExample)
IL (1) IL178905A0 (enExample)
MX (1) MXPA06012321A (enExample)
WO (1) WO2005107785A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003159A1 (en) 2003-07-03 2005-01-13 Koeln Johanna Complement depletion using recombinant human c3-derivatives
US8632780B2 (en) 2004-04-30 2014-01-21 University Of Hawaii Human complement C3 derivates with cobra venom factor-like function
WO2010056399A1 (en) * 2008-11-17 2010-05-20 Incode Biopharmaceutics, Inc. Method and composition for modulating the immune system and various inflammatory conditions comprising complement depletors
RU2549468C2 (ru) * 2013-08-09 2015-04-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт нормальной физиологии имени П.К. Анохина" Российской академии медицинских наук (ФГБУ "НИИНФ им. П.К. Анохина" РАМН") Способ определения стабилизации с3-конвертазы классического пути активации комплемента человека
WO2015192101A1 (en) * 2014-06-12 2015-12-17 University Of Hawaii Uses of humanized cobra venom factor for reducing or preventing immunogenicity
US20190016766A1 (en) * 2015-10-07 2019-01-17 Daniel E. Benjamin Use of improved modulators of complement function as cancer therapeutics
US11903996B2 (en) * 2015-10-07 2024-02-20 David C. Fritzinger Modulators of complement function
CN106472354B (zh) * 2016-10-21 2019-05-31 新希望六和饲料股份有限公司 一种成年鸡用饲料盘
CN106472359B (zh) * 2016-10-21 2019-07-26 新希望六和饲料股份有限公司 一种1-3周龄雏鸡用饲料盘

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661347A (en) * 1982-11-12 1987-04-28 Scripps Clinic Cytotoxic compositions
CA2160127A1 (en) * 1993-04-07 1994-10-13 David C. Fritzinger Dna encoding cobra c3, cvf1, and cvf2
US5714344A (en) * 1993-04-07 1998-02-03 Georgetown University Protease-derivatized CVF
WO1996007738A2 (en) * 1994-09-08 1996-03-14 Imutran Limited Modified human c3 proteins
US6221657B1 (en) * 1995-09-08 2001-04-24 Imutran Limited Modified human C3 DNA sequences and vectors
US5922320A (en) * 1996-06-14 1999-07-13 Georgetown University Recombinant proCVF
WO2005003159A1 (en) * 2003-07-03 2005-01-13 Koeln Johanna Complement depletion using recombinant human c3-derivatives
US8632780B2 (en) * 2004-04-30 2014-01-21 University Of Hawaii Human complement C3 derivates with cobra venom factor-like function
US20100179092A1 (en) * 2006-11-15 2010-07-15 Fritzinger David C Human complement c3 derivatives with cobra venom factor-like function

Similar Documents

Publication Publication Date Title
CN104507489B (zh) 用于预防和治疗类风湿性关节炎的组合物
EP1795203A2 (en) Fhit proteins and nucleic acids and methods based thereon
JP2012067100A (ja) Ｉｌ−２１の誘導体
JPH02504581A (ja) ヒトマンノース結合タンパク質
CN106977593A (zh) 多胜肽、编码该多胜肽的核酸分子、以及该多胜肽的应用
JP2006502702A5 (enExample)
US20080234191A1 (en) Human complement C3 derivates with cobra venom factor-like function
CN112442129B (zh) 肿瘤酶响应型重组焦亡蛋白递药系统及其抗肿瘤用途
JP2008502323A5 (enExample)
AU2005298245B2 (en) A thymus-specific protein
WO2013134249A1 (en) Adipose tissue targeted peptides
JP6181158B2 (ja) ＴＮＦ−α阻害剤としてのＴＡＣＥプロドメインの変異体およびその医学的使用
CN105524139A (zh) 高活性的肿瘤抑制剂及其制法和应用
JP3903503B2 (ja) 可溶性ポリペプチド
CN105884876B (zh) 一种蚯蚓多肽、其编码序列及其应用
TWI888497B (zh) 烏司他丁多肽
US20160272690A1 (en) Yap protein inhibiting polypeptide and application thereof
JP2001515720A (ja) β−デフェンシン
ES2913497T3 (es) Variantes de GM-CSF y métodos de uso
JPH025892A (ja) 組換えヒトインターロイキン―１αポリペプチド
JP5385611B2 (ja) Ｐｆ４とｒａｎｔｅｓとの相互作用に対するアンタゴニスト
ES2290606T3 (es) Procedimientos y composiciones para la inhibicion del crecimiento celular neoplasico.
JP2868800B2 (ja) 癌転移抑制剤
CN100480264C (zh) 一种广谱抑制癌细胞生长的蚯蚓蛋白及其编码序列
RU2006142330A (ru) Производные с3 комплемента человека с функцией, подобной функции фактора яда кобры